Login
E-mail
Password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Riassunto 
Presently, Graham K. Dixon is Chairman for HepaRegeniX GmbH, Head-Research & Development at Zaluvida Holdings Pte Ltd. and CSO, Head-Research & Development at Mithra Pharmaceuticals SA.

He is also on the board of Alligator Bioscience AB and InteRNA Technologies BV.

In his past career he was Senior Vice President-Drug Discovery at Galapagos NV and Chief Scientific Officer of Galapagos Genomics NV (a subsidiary of Galapagos NV), CSO, Head-Research & Development at Onxeo SA, CSO, Head-Research & Development at Addex Therapeutics Ltd., CSO, Head-Research & Development at Sensorion SAS, Chief Scientific Officer for Entomed SA, Head-Research & Development at AstraZeneca Plc and Head-Research & Development at Zeneca (a subsidiary of AstraZeneca Plc), Chief Strategy Officer at F2G Ltd. and Chief Executive Officer at Neem Biotech Ltd.

Graham K. Dixon received a doctorate from Swansea University and an undergraduate degree from the University of Bradford.


Posti e reponsabilitÓ di Graham K. Dixon 
NomeTitolo Da
Mithra Pharmaceuticals SA
(Prodotti farmaceutici)
CSO, Head-Research & Development -
Alligator Bioscience AB (publ)
(Biotecnologia)
Independent Director 2019
HepaRegeniX GmbH Chairman -
Zaluvida Holdings Pte Ltd. Head-Research & Development -
InteRNA Technologies BV Director -


Graham K. Dixon: network personale 
Le notizie pi¨ lette 
21/07CARLOS TAVARES: Stellantis, carenza globale chip proseguirà nel 2022 - Tavares (Ceo)
RE
30/07XAVIER NIEL: Iliad, fondatore Xavier Niel acquisterà quota non posseduta, lascerà borsa
RE
22/07PHILIPPE DONNET: Generali, grandi soci privati potrebbero chiedere a Donnet di non presentare piano - stampa
RE
21/07FRANCESCO GAETANO CALTAGIRONE: Mediobanca, Caltagirone detiene 3,003% al 20 luglio - Consob
RE
Pi¨ notizie


© 2021 People and Ownership :   
Graham K. Dixon : connessioni